Clinical trial • Phase I/II • Infectious Disease|Other
CD40.Pan.CoV vaccine for Healthy volunteers
Phase I/II trial of CD40.Pan.CoV vaccine for Healthy volunteers. 48 participants.
Overview
- Trial Therapeutic Area
- Infectious Disease|Other
- Trial Disease
- Healthy volunteers
- Trial Stage
- Phase I/II
- Drug Modality
- Vaccine
Key dates
- Initial CTIS Submission Date
- 17-12-2024
- First CTIS Authorization Date
- 25-04-2025
Trial design
Phase I/II trial across 7 sites in France.
- Target Sample Size
- 48
Recruitment
- Planned Sample Size
- 48
- Recruitment Window Months
- 22
Geography
- Total Number Of Sites
- 7
- Total Number Of Participants
- 48
France
- Earliest CTIS Part Ii Submission Date
- 31-01-2025
- Latest Decision Or Authorization Date
- 23-03-2026
- Processing Time Days
- 416
- Number Of Sites
- 7
- Number Of Participants
- 48
Sites
- Site Name
- Hopital Saint Louis
- Department Name
- CIC1427
- Contact Person Name
- Juliette SORET DULPHY
- Contact Person Email
- juliette.soret@aphp.fr
- Site Name
- Centre Hospitalier Universitaire De Caen Normandie
- Department Name
- Centre de recherche clinique
- Contact Person Name
- Renaud VERDON
- Contact Person Email
- verdon-r@chu-caen.fr
- Site Name
- CHU Henri Mondor
- Department Name
- Service d'immunologie clinique et maladies infectieuses
- Contact Person Name
- Jean Daniel LELIEVRE
- Contact Person Email
- jean-daniel.lelievre@aphp.fr
- Site Name
- University Hospital Of Clermont-Ferrand
- Department Name
- CIC1405
- Contact Person Name
- Christian DUALE
- Contact Person Email
- cduale@chu-clermontferrand.fr
- Site Name
- Centre Hospitalier Universitaire De Nantes
- Department Name
- CIC1413
- Contact Person Name
- Maeva LEFEBVRE
- Contact Person Email
- maeva.lefebvre@chu-nantes.fr
- Site Name
- Centre Hospitalier Universitaire De Lille
- Department Name
- CIC 14036 Institut Coeur Poumon
- Contact Person Name
- Dominique DEPLANQUE
- Contact Person Email
- dominique.deplanque@chru-lille.fr
- Site Name
- Hôpital Cochin
- Department Name
- CIC 1417 Cochin Pasteur
- Contact Person Name
- Odile LAUNAY
- Contact Person Email
- odile.launay@aphp.fr
Sponsor
Primary sponsor
- Full Name
- ANRS Maladies Infectieuses Emergentes
- Organisation Type
- Laboratory/Research/Testing facility
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- CD40.Pan.CoV vaccine
- Modality
- Vaccine
Related trials
Other published trials that may interest you.